|
|
40
|
|
|
A5916
|
|
|
DOXORUBICIN 50MG SOLN FOR INJ (EBA/COL)
|
|
|
DOXORUBICIN
|
|
|
DOXORUBICIN
|
|
|
50MG VIAL
|
|
|
BQ
|
|
|
34.93
|
|
|
34.93
|
|
|
50MG
|
|
|
SOLUTION FOR
|
|
|
0
|
|
|
VIAL
|
|
|
EBA
|
|
|
EBEW ARZNEIMITTLE GES.MBH
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
Price Change
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
2022-01-18
|